RECURRENT GLIOBLASTOMA MULTIFORME: IMPLICATION OF NONENHANCING LESIONS ON BEVACIZUMAB TREATMENT

被引：0
|
作者：
Alexandru, Daniela [1 ]
Bota, Daniela [1 ]
Linskey, Mark E. [1 ]
机构：
[1] UCI Med Ctr, Orange, CA USA
来源：
NEURO-ONCOLOGY | 2011年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：143 / 143
页数：1
相关论文
共 50 条
  • [31] Treatment of recurrent glioblastoma multiforme with gliasite brachytherapy
    Chan, TA
    Weingart, JD
    Parisi, M
    Hughes, MA
    Olivi, A
    Borzillary, S
    Alahakone, D
    Detorie, NA
    Wharam, MD
    Kleinberg, L
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (04): : 1133 - 1139
  • [32] Treatment of recurrent glioblastoma multiforme with fotemustine and brachytherapy
    Fabrini, M.
    Pasqualetti, F.
    Romanini, A.
    Vannozzi, R.
    Scotti, V.
    Grandinetti, A.
    Grespi, S.
    Cionini, L.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S300 - S301
  • [33] Treatment of recurrent glioblastoma multiforme with fotemustine and brachitherapy
    Pasqualetti, F.
    Scotti, V
    Grandinetti, A.
    Grespi, S.
    Giraldi, D.
    Fabrini, M. G.
    Romanini, A.
    Vannozzi, R.
    Salvadori, B.
    Ricci, S.
    Cionini, L.
    ANNALS OF ONCOLOGY, 2006, 17 : XI61 - XI61
  • [34] New treatment options in the management of glioblastoma multiforme: a focus on bevacizumab
    Moustakas, Argirios
    Kreisl, Teri N.
    ONCOTARGETS AND THERAPY, 2010, 3 : 27 - 38
  • [35] BEVACIZUMAB AND IRINOTECAN IN THE TREATMENT OF PATIENTS WITH RECURRENT GLIOBLASTOMA
    Naskhletashvili, D. R.
    Gorbounova, V.
    Bychkov, M.
    Bekyashev, A.
    Karakhan, V.
    Aloshin, V.
    Fu, R.
    Moskvina, E.
    NEURO-ONCOLOGY, 2012, 14 : 59 - 59
  • [36] Radiographic evaluation of recurrent glioblastoma multiforme (gbm) in patients treated with bevacizumab and irinotecan
    Andre, Jalal
    Spearman, Kenneth
    Lu, Stanley
    Raval, Sumul
    NEURO-ONCOLOGY, 2007, 9 (04) : 575 - 575
  • [37] Bevacizumab combined with irinotecan for recurrent glioblastoma multiforme—improvement over available therapy?
    Sajeel Chowdhary
    Eric T Wong
    Nature Clinical Practice Neurology, 2008, 4 (5): : 242 - 243
  • [38] Radiographic evaluation of recurrent glioblastoma multiforme (GBM) in patients treated with bevacizumab and irinotecan
    Andre, J.
    Spearman, K.
    Lu, S.
    Hwang, S.
    Dorsett, L.
    Raval, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [39] Complete remission after bevacizumab plus temozolomide in a patient with recurrent glioblastoma multiforme
    Kilickap, Saadettin
    Oztoprak, Ibrahim
    Yucel, Birsen
    ACTA ONCOLOGICA, 2012, 51 (04) : 544 - 546
  • [40] A randomized phase II study of carboplatin and bevacizumab in recurrent glioblastoma multiforme (CABARET)
    Field, Kathryn Maree
    Simes, John
    Wheeler, Helen
    Hovey, Elizabeth J.
    Nowak, Anna K.
    Cher, Lawrence
    Brown, Chris
    Livingstone, Ann
    Sawkins, Kate
    Rosenthal, Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345